Quantinno Capital Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.67M Buy
90,997
+26,202
+40% +$432K ﹤0.01% 2351
2026
Q2
$945K Buy
64,795
+15,504
+31% +$150K ﹤0.01% 2603
2026
Q1
$366K Buy
49,291
+8,796
+22% +$92.6K ﹤0.01% 2924
2025
Q4
$476K Buy
40,495
+8,106
+25% +$87.5K ﹤0.01% 2479
2025
Q3
$250K Buy
+32,389
New +$227K ﹤0.01% 2605

Other funds holding NEO

Quantinno Capital Management's NEO Position: Q3 2026 in Review

Quantinno Capital Management increased its NeoGenomics (NEO) stake by 40% in Q3 2026, buying an estimated $432K and bringing the position to 90,997 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2351.

Quantinno Capital Management first reported a position in NEO in Q3 2025 and has held it in 5 quarters since. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Quantinno Capital Management held 90,997 shares of NeoGenomics worth $1.67M as of Q3 2026.
  • Quantinno Capital Management bought 26,202 NeoGenomics shares in Q3 2026, an estimated $432K.
  • NeoGenomics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2351 holding.
  • Quantinno Capital Management first reported a position in NeoGenomics in Q3 2025 and has held it in 5 quarters since.
  • 294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.